Perimenopause is the transition itself, the years of hormonal flux before periods stop, when cycles turn irregular and hot flushes, night sweats, broken sleep, and a rise in low mood begin. It is very treatable. Hormone therapy is the most effective option for hot flushes, and started near menopause it appears to slow early artery changes. For women who cannot take hormones or prefer not to, fezolinetant, certain antidepressants, and cognitive behavioral therapy all have trial evidence.
Some popular supplements, black cohosh and soy among them, have not beaten placebo. Contraception is still needed and can double as symptom control. Bleeding after periods have fully stopped is the one thing that always needs checking.
Practice Ranking
Every practice we track for Perimenopause, ranked by how well the evidence supports it for this condition. Strength describes the evidence, not our endorsement.
3 practices · 1 to start with
| # | Practice | Evidence | Type | Cost | Effort | Results In | Add to plan |
|---|---|---|---|---|---|---|---|
| 1 | Resistance Training Heavy strength and impact training protects bone during the transition; exercise has not been shown to reduce hot flushes specifically. | Moderate | Self-Directed | Free to $$ | Moderate to Hard | Weeks to Months | |
| 2 | Sleep Restriction & Stimulus Control CBT for insomnia is the best-supported non-drug fix for perimenopausal sleep disruption. | Moderate | Self-Directed | Free to $$ | Hard | Weeks | |
| 3 | Cognitive Behavioral Therapy CBT reduces hot-flash bother, a non-hormonal option. | Moderate | Self-Directed | Free to $$ | Moderate to Hard | Weeks | |
Default order puts the best-supported practices first, with self-directed care ahead of clinical options. Click any row to open the practice.
What It Is
Perimenopause is the transition into menopause, the years when the ovaries wind down and periods have not yet fully stopped. It is a staged, multi-year phase. The international STRAW+10 staging describes an early phase, when cycle length starts to vary persistently by 7 days or more, and a late phase, when gaps of 60 days or more open up between periods, marking the last year or two before the final one.
Estrogen and FSH swing from day to day through this time, so a single blood test cannot pin down where a woman is while cycles continue. That is one reason women in this phase are so often told they are too young, or handed a test that cannot answer the question.
The bleeding changes follow a pattern. Cycles tend to shorten first, then lengthen and skip. Heavier or longer bleeding is common, because ovulation becomes erratic and the uterine lining is exposed to estrogen without regular progesterone to shed it on schedule. Irregularity itself is expected. Very heavy or prolonged bleeding, bleeding between periods, and bleeding after sex are not, and each is checked.
Bleeding a year or more after periods have fully stopped is always checked, whatever else is happening.
The symptom picture comes from the same hormonal flux. Hot flushes and night sweats rise, sleep breaks up, and mood can dip. The rise in low mood is under-recognized: it happens even in women who have never been depressed before, and it is treatable, not something to wait out.
Two common conditions produce much the same symptoms and improve with neither hormones nor herbs:
- Thyroid disease causes heat intolerance, sweating, palpitations, disturbed sleep, and fatigue.
- Iron deficiency causes the same, and is easy to reach here because perimenopausal bleeding can be heavy.
Both are cheap to check with a blood test.
What Helps
Hormone therapy relieves hot flushes and night sweats better than anything else tested, so it is the first option for women who want it and have no reason to avoid it. Started near menopause, under 60 or within 10 years of the final period, its benefits generally outweigh its risks, and that early start also appears to slow thickening of the artery wall. The balance shifts with older age, longer time since menopause, and a personal or family history of breast cancer, clots, or cardiovascular disease.
For women who cannot take hormones or prefer not to, three drugs have trial evidence. Each is weaker than estrogen for flushes, and each is a reasonable option:
- Fezolinetant, a pill that blocks the brain signal driving flushes.
- Escitalopram, an antidepressant.
- Venlafaxine, an SNRI that came closest to low-dose estrogen when the two were compared head to head.
Cognitive behavioral therapy works on a different target: how much the flushes and night sweats intrude on daily life, which it lowers even when the number of flushes barely changes. When broken sleep becomes a problem of its own and outlasts the flushes, CBT for insomnia is the best-evidenced sleep treatment, and it works while flushes continue.
Bone loss speeds up in the last years before periods stop, so loading the skeleton matters now. Heavy, supervised strength and impact training can add bone in years when the usual trend is loss.
Contraception is still part of the picture, because fertility falls but does not reach zero until periods have been gone 12 months. The combined pill can provide that contraception while steadying erratic, heavy bleeding, and in suitable women it eases hot flushes too. For heavy bleeding on its own, the hormonal coil has the strongest evidence.
The Research & Studies
Everything here is based on the research we have collected and checked, sorted into groups and ordered with the strongest evidence first. Click any claim to open the studies behind it.
Menopause And Vasomotor
Hormone therapy is the most effective treatment for hot flushes, its benefits outweighing risks under 60 or within 10 years of menopause
Hormone therapy relieves hot flushes and night sweats better than anything else tested. For women who are having symptoms and are under about 60 or within ten years of their last period, the major menopause society judges that the benefits usually outweigh the risks.
The 2022 Hormone Therapy Position Statement of The North American Menopause Society, an evidence review by an expert panel, states that hormone therapy remains the most effective treatment for vasomotor symptoms and the genitourinary syndrome of menopause. It frames the decision around timing: for women who begin therapy before age 60 or within 10 years of menopause onset and have no contraindications, the favorable benefit-to-risk ratio supports treatment of bothersome symptoms and prevention of bone loss. Risks rise with older age, longer time since menopause, and the type and route of therapy.
The study · 1
The 2022 hormone therapy position statement of The North American Menopause Society · Menopause 2022
Fezolinetant cut moderate-to-severe hot flushes by 2.55 more per day than placebo
Fezolinetant is a newer non-hormonal pill for women who cannot or would rather not take hormones. In its main trial it cut moderate-to-severe hot flushes by about two and a half more per day than a placebo, starting within a week.
SKYLIGHT 1 was a 12-week, phase 3, randomized, double-blind, placebo-controlled trial in 527 women aged 40 to 65 with an average of seven or more moderate-to-severe hot flushes per day, followed by a 40-week extension. Fezolinetant is a neurokinin 3 receptor antagonist that acts on the brain's temperature-control center. The 45 mg dose reduced hot-flush frequency by 2.55 more per day than placebo at week 12 (P<0.001) and severity by 0.20 (P=0.007), with benefit from week 1 and maintained to 52 weeks. Liver enzyme elevations were uncommon in the trial; liver monitoring is part of prescribing. The trial was funded by the manufacturer.
The study · 1
Escitalopram cut hot flushes by 1.41 more per day than placebo, halving them for 55% of women
The antidepressant escitalopram, at a low dose, modestly reduces hot flushes, useful for women who cannot or prefer not to take hormones. In its trial, just over half the women on it had their hot flushes cut in half, against about a third on placebo.
This multicenter, 8-week, double-blind trial randomized 205 healthy menopausal women (mean 9.8 hot flushes per day at baseline) to escitalopram 10 to 20 mg or placebo. Escitalopram reduced frequency by 1.41 more per day than placebo (95% CI 0.13 to 2.69, P<0.001), and 55% of women reached at least a 50% reduction against 36% on placebo (P=0.009). Bother and severity also improved. Effects were modest relative to hormone therapy but meaningful for a non-hormonal option, and symptoms returned somewhat after stopping.
The study · 1
Venlafaxine cut hot flushes by 1.8 per day against estrogen's 2.3, a gap of just 0.6
In a head-to-head trial, the non-hormonal drug venlafaxine came close to low-dose estrogen for hot flushes. Estrogen cut them by about 2.3 a day more than placebo, venlafaxine by about 1.8, a gap small enough that for many women the non-hormonal option is a real alternative.
This 8-week, three-arm randomized trial (MsFLASH network, 339 women) compared low-dose oral estradiol 0.5 mg, venlafaxine 75 mg, and placebo. Frequency fell to 3.9 per day on estradiol (52.9% reduction), 4.4 on venlafaxine (47.6%), and 5.5 on placebo (28.6%). Estradiol beat placebo by 2.3 per day (P<0.001) and venlafaxine by 1.8 (P=0.005); estradiol beat venlafaxine by only 0.6 per day (P=0.09), a difference the authors judged small and of uncertain clinical relevance. Both were well tolerated.
The study · 1
Joffe et al., Low-dose estradiol and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms: a randomized clinical trial · JAMA Intern Med 2014
CBT lowered how much hot flushes and night sweats bother you by about 2 points on a 10-point scale
Cognitive behavioral therapy changes how much hot flushes and night sweats bother you, rather than how many you have. Both a group course and a self-help booklet worked in the trial, and the benefit was still present at six months, though smaller than at six weeks.
The MENOS 2 trial randomized 140 women with problematic hot flushes and night sweats to group CBT, self-help CBT, or usual care. Both CBT arms beat usual care on the problem-rating scale at 6 weeks (adjusted mean differences 2.12 and 2.08 on a 10-point scale); by 26 weeks the difference had narrowed to about 1.33 for group CBT and 1.19 for self-help, still statistically significant. What moved most was the distress and interference; hot-flush frequency changed much less, though night-sweat frequency did fall significantly. Participants could not be blinded, and the trial was run by the group that developed the intervention.
The study · 1
Exercise did not specifically cut hot flushes
Exercise is worth doing in the transition, but not as a way to reduce hot flushes: the trials do not show it works for that. Its real value here is for bone, heart and mood, not the flushes.
The Cochrane review Exercise for vasomotor menopausal symptoms searched for randomized trials of exercise against no active treatment, hormone therapy, or other interventions for hot flushes and night sweats. It found few eligible trials and insufficient evidence to show that exercise reduces vasomotor symptoms specifically. This sits alongside strong evidence that exercise benefits bone, cardiovascular health and mood through midlife, so the finding narrows the claim to the flushes rather than dismissing exercise.
The study · 1
Daley et al., Exercise for vasomotor menopausal symptoms · Cochrane Database Syst Rev 2014
Black cohosh did not reduce hot flushes more than placebo across 16 trials and 2,027 women
Black cohosh is one of the most popular herbs sold for the transition, but the pooled trials do not show it beating a placebo for hot flushes. Hot flushes also respond strongly to placebo, which is part of why so many products feel like they work.
The Cochrane review Black cohosh (Cimicifuga spp.) for menopausal symptoms pooled 16 randomized trials in 2,027 perimenopausal and postmenopausal women. It found insufficient evidence to support black cohosh, with no statistically significant difference from placebo in the frequency of hot flushes or in a composite menopausal symptom score, though the authors noted trial quality and heterogeneity limited firm conclusions and called for better studies. Rare liver injury has been reported with black cohosh products, which is why regulators require a caution on the label.
The study · 1
Leach and Moore, Black cohosh (Cimicifuga spp.) for menopausal symptoms · Cochrane Database Syst Rev 2012
Soy and other phytoestrogens did not clearly reduce hot flushes more than placebo
Soy and other plant-estrogen supplements do not clearly beat placebo for hot flushes overall. There is a hint that concentrated genistein extracts might help a little, but the effect is small and the placebo response in these trials is large.
The Cochrane review Phytoestrogens for menopausal vasomotor symptoms pooled numerous randomized trials of dietary soy, soy extracts, red clover and other phytoestrogens. Overall there was no conclusive evidence of a reduction in hot-flush frequency or severity, and heterogeneity was high. A subgroup signal suggested genistein-concentrated extracts might reduce flush frequency, but the reviewers cautioned that the placebo response was substantial (some placebo arms improved by up to 50%), which makes small active effects hard to read. Safety over the short term was reasonable, with long-term endometrial and breast safety of concentrated extracts not fully established.
The study · 1
Lethaby et al., Phytoestrogens for menopausal vasomotor symptoms · Cochrane Database Syst Rev 2013
Measurement And Diagnosis
Early perimenopause is cycle shifts of 7 days or more, late is gaps of 60 days or more
Perimenopause has an early and a late phase. Early: your cycle starts varying by a week or more. Late: you skip periods, with gaps of two months or more. Because hormones swing rather than fall steadily, one blood test cannot pin down where you are.
The Stages of Reproductive Aging Workshop +10 (STRAW+10) is the international consensus staging of the menopausal transition, built by re-examining accumulated cohort data. It anchors early perimenopause (stage -2) to persistent variation of 7 days or more in consecutive cycle lengths, and late perimenopause (stage -1) to an interval of amenorrhea of 60 days or more. FSH is elevated but variable across both stages, which is why the criteria are based on the bleeding pattern rather than on a hormone level. The system is descriptive: it names where a woman is, not what to do about it.
The study · 1
Harlow et al., Executive summary of the Stages of Reproductive Aging Workshop +10: addressing the unfinished agenda of staging reproductive aging · Menopause 2012
Cycles shorten, then lengthen and skip, and bleeding can turn heavy as ovulation gets erratic
It is normal for periods to first come closer together, then further apart, and to sometimes get heavier or longer. This happens because ovulation becomes irregular, so the lining is not shed on a steady schedule. Common does not mean nothing needs checking: very heavy or between-period bleeding still warrants a look.
Reviews of menstruation across the transition describe a characteristic sequence: cycles typically shorten in early perimenopause as the follicular phase contracts, then become long and skipped in late perimenopause. Anovulatory cycles, in which no corpus luteum forms, leave the endometrium under unopposed estrogen, which can produce heavy or prolonged menstrual bleeding. The clinical point is that irregularity itself is expected, while flooding, clots, bleeding between periods, or bleeding after sex are not, and are the signs that need assessment.
The study · 1
Harlow SD, Paramsothy P, Menstruation and the menopausal transition · Obstet Gynecol Clin North Am 2011
Mood & stress
Low mood was over four times as likely in the transition, even with no past depression
The transition raises the risk of low mood, even in women who have never been depressed before. In one study, high depression-symptom scores were more than four times as common during perimenopause as beforehand. Low mood in these years is real and treatable, not something to wait out.
The Penn Ovarian Aging Study followed women with no prior depression through the transition. High scores on the CES-D depression scale were 4.29 times more likely during the transition than premenopausally (95% CI 2.39 to 7.72), and a PRIME-MD diagnosis of a depressive disorder 2.50 times more likely (95% CI 1.25 to 5.02). Rising and more variable FSH, LH and estradiol around each woman's own mean were each associated with the higher scores, after adjustment for smoking, BMI, PMS, hot flushes, poor sleep, health status, employment and marital status.
The study · 1
Freeman et al., Associations of hormones and menopausal status with depressed mood in women with no history of depression · Arch Gen Psychiatry 2006
Antidepressants and psychotherapy stay first-line, and estrogen lifts mood in perimenopause but not after
Low mood in the transition is treated much as depression is at any age: talking therapy and antidepressants (SSRIs or SNRIs) work. In perimenopause specifically, estrogen also has a mood-lifting effect and can be an option when hot flushes are part of the picture, which it is not once a woman is fully postmenopausal.
The Guidelines for the Evaluation and Treatment of Perimenopausal Depression, produced jointly by the North American Menopause Society and the National Network of Depression Centers Women and Mood Disorders Task Group, reviewed the evidence and set out recommendations. Proven antidepressant therapies (SSRIs, SNRIs) and psychotherapy remain first-line. Estradiol has demonstrated antidepressant efficacy in perimenopausal women in randomized trials, an effect not shown in postmenopausal women, so the reproductive stage matters to the choice.
The study · 1
Maki et al., Guidelines for the Evaluation and Treatment of Perimenopausal Depression: Summary and Recommendations · J Womens Health (Larchmt) 2019
Heart And Vascular
Estrogen started within 6 years of menopause slowed artery-wall thickening, started 10 or more years later it did not
When hormone therapy is started matters. In a randomized trial, estrogen slowed the build-up in the artery wall in women who began it within six years of menopause, but not in women who started ten or more years later. This is the evidence behind the idea that hormone therapy started near menopause reads differently than starting it much later.
The Early versus Late Intervention Trial with Estradiol (ELITE) randomized 643 healthy postmenopausal women, stratified by time since menopause (under 6 years or 10 or more years), to oral 17-beta-estradiol or placebo and tracked carotid-artery intima-media thickness. Progression was slower on estradiol than placebo in the early group (0.0044 vs 0.0078 mm/year) but not the late group (0.0100 vs 0.0088 mm/year), interaction P=0.007. A CT measure of actual coronary plaque showed no significant difference in either group, so the finding is on an imaging marker of early atherosclerosis, not on heart attacks or deaths.
The study · 1
Hodis et al., Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol (ELITE) · N Engl J Med 2016
Sleep
CBT for insomnia dropped the insomnia score by 9.9 points against 4.7, with 84% out of the insomnia range by 24 weeks
When sleep falls apart in the transition, CBT for insomnia helps even while hot flushes continue. In the trial, most women who did it were no longer in the insomnia range six months later, against fewer than half of the comparison group.
This MsFLASH trial randomized 106 perimenopausal and postmenopausal women (mean age 54 to 55) with insomnia and hot flushes to telephone-based CBT for insomnia or to menopause education. The Insomnia Severity Index fell 9.9 points on CBT-I against 4.7 on the control, a 5.2-point difference at 8 weeks; by 24 weeks 84% of the CBT-I group were in the no-insomnia range against 43% of controls. Hot-flush frequency itself barely changed; what improved was the sleep around the flushes.
The study · 1
McCurry et al., Telephone-based cognitive behavioral therapy for insomnia in perimenopausal and postmenopausal women with vasomotor symptoms: a MsFLASH randomized clinical trial · JAMA Intern Med 2016
Bone Density
Heavy strength and impact training raised spine bone density 2.9% while a control group lost 1.2%
Bone loss speeds up in the last years before periods stop. Heavy, properly supervised strength and impact training can build bone rather than just slow the loss: in one trial spine density rose by about 3% while an easy-exercise group kept losing it.
The LIFTMOR randomized controlled trial assigned 101 postmenopausal women with low bone mass (mean age 65) to 8 months of twice-weekly, 30-minute supervised high-intensity resistance and impact training (5 sets of 5 reps above 85% of one-rep maximum, plus impact) or to a home-based low-intensity program. The training group gained 2.9% in lumbar-spine bone density against a 1.2% loss in controls (P<0.001) and gained at the femoral neck too, with improved functional performance and only one minor adverse event under supervision. The direct evidence is in older women with established low bone mass; the mechanism, that high-magnitude loading builds and preserves bone, is why it is relevant to the transition years when loss accelerates.
The study · 1
Watson et al., High-Intensity Resistance and Impact Training Improves Bone Mineral Density and Physical Function in Postmenopausal Women With Osteopenia and Osteoporosis: The LIFTMOR Randomized Controlled Trial · J Bone Miner Res 2018
Fertility
Pregnancy is still possible until periods have been gone 12 months, and the combined pill can steady cycles too
You can still get pregnant during the transition, so contraception is still needed until periods have been gone a year. The combined pill can do two jobs at once: prevent pregnancy and steady the irregular, heavy bleeding, and it can ease hot flushes too.
A consensus conference on contraception in women beyond 40 years of age reviewed the evidence and concluded that fertility is reduced but not absent and that contraception should be continued through the transition. Standard clinical guidance holds that spontaneous ovulation, and therefore pregnancy, can still occur until 12 months without a period confirm menopause, and that combined hormonal contraception in appropriately selected women (no smoking, no migraine with aura, no cardiovascular contraindication) provides effective contraception while also regulating cycle irregularity and easing vasomotor symptoms. Progestogen-only methods and the levonorgestrel intrauterine system are options where estrogen is contraindicated, and the IUS additionally treats heavy menstrual bleeding.
The study · 1
Consensus conference results on contraception in women beyond 40 years of age · Eur J Contracept Reprod Health Care 2025
Menstrual And Pms
The hormonal IUS beat usual medical treatment for heavy bleeding, 13.4 points more on a 100-point quality-of-life scale
Heavy periods are common in the transition, and the hormonal coil (levonorgestrel IUS) treats them better than the usual tablets. In a trial of 571 women it improved bleeding-related quality of life more than pills like tranexamic acid or the combined pill, and most women were still using it two years later. It also provides contraception, which is still needed.
ECLIPSE was a pragmatic, multicenter randomized trial that assigned 571 women presenting to primary care with heavy menstrual bleeding to the levonorgestrel-releasing intrauterine system or to usual medical treatment (tranexamic acid, mefenamic acid, combined estrogen-progestogen, or progesterone alone). The primary outcome, the patient-reported Menorrhagia Multi-Attribute Scale, improved in both groups by 6 months and stayed improved over 2 years, with the levonorgestrel-IUS group gaining 13.4 points more (95% CI 9.9 to 16.9, P<0.001). Gains were larger across all MMAS domains and most quality-of-life domains. At 2 years, 64% of the IUS group were still using their assigned treatment against 38% of the usual-treatment group (P<0.001). There was no significant difference in rates of surgery or in serious adverse events. The trial was publicly funded by the UK National Institute for Health Research.
The study · 1
Gupta et al., Levonorgestrel intrauterine system versus medical therapy for menorrhagia (ECLIPSE) · N Engl J Med 2013
What Does Not Help Much
The two most popular remedies test level with placebo. Hot flushes come and go on their own and respond strongly to expectation, so almost anything taken during a bad stretch feels like it worked. Black cohosh, the most-sold herb for the transition, has not beaten placebo for hot flushes across the pooled trials. Soy and other phytoestrogen supplements have not clearly beaten it either. Exercise is worth doing in these years for bone, heart, and mood; the trials do not show it reduces hot flushes.
How It Works
The symptoms trace to one thing: the ovaries wind down unevenly, so estrogen swings from day to day and sometimes runs higher than before.
Hot flushes and night sweats start in the brain. As estrogen shifts, the temperature-regulating part of the hypothalamus narrows the range of core temperature it tolerates, so a small rise that once went unnoticed now sets off a full flush and sweat. A cluster of neurons using a signal called neurokinin B drives that response, which is why fezolinetant, a drug that blocks the signal, works without hormones.
The heavy, unpredictable bleeding comes from the same erratic ovulation. Without a regular corpus luteum, the lining sits under estrogen with too little progesterone to shed it on schedule, so it builds up and sheds unevenly.
Falling estrogen also speeds bone loss and contributes to low mood, which is why strength training and treating low mood as its own problem both belong in the plan.
Go Deeper
- Menopause and hot flashes: the years after the final period, the risks of hormone therapy in plain numbers, and vaginal estrogen for dryness.
- Menopausal hormone therapy: the full hormone decision, the routes and timing, and the non-hormonal drugs in depth.
- Osteoporosis: protecting the bone that thins fastest through the transition.
- Depression: treating the low mood that rises in these years, at any age.
- Insomnia: when the broken sleep becomes its own problem and outlasts the flushes.
- CBT for insomnia: the structured sleep program that worked even while hot flushes continued.
- Resistance training: the heavy strength work that builds bone and muscle through midlife.
The Chinese Medicine View
The Chinese Medicine View
Chinese medicine reads the transition as the Kidneys emptying with age, the essence that governs the reproductive years waning so the cooling, moistening Yin depletes first and the warmth it once held rises as empty heat, heat that comes from an absence rather than an excess. That frame maps closely onto hot flushes and night sweats. The Nei Jing counts a woman's life in seven-year phases, the reproductive essence, the Tian Gui, waning around the seventh, so the cycle grows irregular and then ends. Because periods are still coming in perimenopause, two systems that settle later are still active and unsteady now: the Liver, which moves the Qi and can stagnate under the hormonal swings, and the Chong and Ren vessels, which govern the menstrual flow. The modern trials of one fixed formula given to everyone come out level with placebo, and that is not how the medicine is practiced, where the prescription is matched to the pattern; the herbal evidence for the hot flushes and night sweats is limited, and hormone therapy is the tested mainstay for those. Read the patterns as an interpretive lens, and a practitioner reads the pulse and tongue a page cannot.
The central picture as the essence wanes: hot flushes rising to the face and chest, night sweats that come in sleep and stop on waking, heat in the palms and soles, dry mouth and eyes, vaginal dryness, weak low back and knees. Points toward nourishing Yin, the Liu Wei Di Huang and Zhi Bai Di Huang families.
Distinctive to the still-cycling years: irritability that surprises you, rib-side and breast distension, tension headaches, premenstrual intensification, and cycles that swing. The Xiao Yao San family, modified toward cooling once the stagnation has turned to heat.
The vessels that govern the menses losing their hold: erratic, heavy or prolonged bleeding, flooding that gives way to spotting. This is the pattern that maps most closely to the heavy, unpredictable bleeding of the transition, treated by consolidating and regulating these vessels.
Yin no longer anchoring the Shen: waking at two or three, palpitations, anxiety with no object, a mind that will not settle. Tian Wang Bu Xin Dan is the classical answer.
Flushes and sweating together with cold feet, aversion to cold, low libido and exhaustion. Common in the transition, and what Er Xian Tang was built for, warming Yang tonics paired with fire-draining herbs in the one prescription.
Cautions
Extra restraintEverything to be aware of is here, in one place. This practice suits most healthy people; a few situations call for real care.
About 90% of endometrial cancers show up as bleeding after menopause, and roughly 9% of postmenopausal bleeding is cancer
This systematic review and meta-analysis (Clarke et al., National Cancer Institute) pooled studies on the relationship between postmenopausal bleeding (PMB) and endometrial cancer. Across the data, roughly 90% of women diagnosed with endometrial cancer reported PMB, and the pooled prevalence of endometrial cancer among women presenting with PMB was about 9% (varying with hormone-therapy use and other factors). PMB is far more often caused by benign conditions such as atrophy or polyps, but because it is the presenting symptom in the large majority of endometrial cancers, it is the signal that triggers investigation, typically transvaginal ultrasound and endometrial sampling.Clarke et al., Association of Endometrial Cancer Risk With Postmenopausal Bleeding in Women: A Systematic Review and Meta-analysis
Hormone therapy is a decision made with a clinician
Hormone therapy is not for everyone. The balance is generally favorable for a woman who begins near menopause, under 60 or within 10 years of her final period, and it shifts with a personal or family history of breast cancer, blood clots, or cardiovascular disease, and with how the hormone is taken. Do not start or stop a prescribed hormone because of anything on this page; that conversation belongs with the person who prescribes it.
The combined pill is not suitable for everyone
The combined pill can steady erratic cycles and provide contraception, but smoking, migraine with aura, high blood pressure, and cardiovascular risk are reasons to choose a non-estrogen method instead, such as a progestogen-only pill or the hormonal coil. A clinician sorts out which method fits.
Rule out the look-alikes before you treat
Thyroid disease and iron deficiency produce much the same symptoms as the transition and respond to neither hormones nor herbs. A blood test, which you can arrange yourself or through a doctor, settles it cheaply before months are spent treating the wrong thing, and iron deficiency is common here because the bleeding can be heavy.
Compounded "bioidentical" hormones and saliva tests
Custom-compounded "bioidentical" hormones marketed as safer than regulated therapy carry no advantage shown over the FDA-approved bioidentical hormones, with less oversight of dose and purity, and the saliva hormone tests sold to tailor them do not track a reliable target. Black cohosh, sold widely for the transition, has also been linked to rare liver injury, a separate matter from whether it works.
Most of the transition is manageable with the levers above. Educate yourself, start with what you can do yourself, and consult a licensed practitioner if you have questions or a history that needs weighing. This is here to inform your choice, not make it for you.
When to See Someone
Most of the transition is not dangerous and needs no doctor. These are the signs that do. See a doctor about any of them, and urgently for the ones marked, if you have:
- Any bleeding a year or more after your last period. Bleeding once periods have fully stopped is always worth investigating, because it is how the treatable problems are found early: about 90% of endometrial cancers first appear as bleeding of this kind, and roughly 9% of women who bleed after menopause turn out to have one. Most cases are something benign, but it is checked every time, and spotting counts.(seek urgent care)
- Very heavy bleeding, flooding or clots, soaking through protection every hour, periods lasting more than seven days, bleeding between periods, or bleeding after sex. Heavy bleeding is common in the transition and still worth checking, both for low iron and to rule out fibroids, polyps, or endometrial disease.
- Persistent low mood, loss of interest, or thoughts of harming yourself. The risk of low mood rises during the transition even in women who have never been depressed before, and it is treatable.(seek urgent care)
- New fatigue, breathlessness, or palpitations at rest, which point more at low iron from heavy bleeding, or at the thyroid, than at the transition, and are worth a blood test.
- A new breast lump, a nipple change, or a change in the skin of the breast.
None of this is meant to alarm you. The transition is manageable and much of it responds well to the options above; the bleeding signs are here because bleeding is the one symptom where getting it checked early matters most.
Common Questions
Can a blood test tell me if I am in perimenopause?
Not reliably, while your cycles are still coming. FSH rises through the transition, but it swings from day to day rather than climbing steadily, so a single result can look normal one week and menopausal the next. The staging that clinicians use is based on your bleeding pattern: persistent cycle-length shifts of 7 days or more mark early perimenopause, and gaps of 60 days or more mark the late phase (Harlow, Menopause 2012). A test is more useful for ruling out the look-alikes, thyroid disease and iron deficiency, than for confirming the transition.
What is the most effective treatment for hot flushes and night sweats?
Hormone therapy, by a clear margin, and for women who are having symptoms and are under 60 or within 10 years of their final period the major menopause society judges the benefits generally outweigh the risks (NAMS position statement, Menopause 2022). When hormones are not the choice, fezolinetant cut moderate-to-severe hot flushes by 2.55 more per day than placebo (Lederman, Lancet 2023), the antidepressant escitalopram cut them by 1.41 more per day with 55% of women at least halving their flushes against 36% on placebo (Freeman, JAMA 2011), and CBT lowers how much they bother you without changing how often they come (Ayers, Menopause 2012).
Does it matter when hormone therapy is started?
It appears to, for the arteries. In the ELITE trial, oral estradiol slowed the thickening of the carotid artery wall in women who began it within 6 years of menopause, but not in women who started 10 or more years later (Hodis, N Engl J Med 2016). The measure was an ultrasound marker of early artery disease rather than heart attacks, so it supports the timing idea without proving hormone therapy prevents heart events. It is part of why starting near menopause reads differently from starting much later.
Do black cohosh or soy help hot flushes?
Not measurably better than placebo. Black cohosh came out level with placebo across 16 trials and 2,027 women (Leach & Moore, Cochrane 2012), and soy and other phytoestrogens did not clearly beat placebo either (Lethaby, Cochrane 2013). Hot flushes respond strongly on their own, so the placebo arms of these trials improved a great deal, which is why a remedy taken during a bad stretch feels like it worked when a controlled trial shows no gain over placebo. Black cohosh has also been linked to rare liver injury.
Do I still need contraception, and can it help the symptoms too?
Yes to both. Fertility falls through the forties but does not reach zero, so contraception is still recommended through the transition (Consensus conference, Eur J Contracept Reprod Health Care 2025). In standard clinical practice it is continued until periods have been absent for a full 12 months. The combined pill can steady erratic, heavy cycles while providing contraception, and in suitable women it also eases hot flushes, an option for those without smoking, migraine with aura, or cardiovascular risk. For heavy menstrual bleeding, the hormonal coil improved bleeding-related quality of life more than usual tablets in a trial of 571 women, and most were still using it two years later (Gupta, N Engl J Med 2013).
What helps the broken sleep and the low mood?
For sleep, start with a cooler bedroom and lighter bedding against the night sweats, and if the broken sleep becomes its own problem, CBT for insomnia is the best-evidenced treatment and worked even while flushes continued, moving 84% of women out of the insomnia range by 24 weeks against 43% of controls (McCurry, JAMA Intern Med 2016). For mood, the low mood that rises in these years is treated much as depression is at any age, with talking therapy and antidepressants, and estrogen has a mood-lifting effect in perimenopause specifically when flushes are also present (Maki, J Womens Health 2019).
Explore Related
Other pages this one connects to, by the evidence they share, the outcomes they touch, and the ground they cover.
All 18 sources on this page independently checked and cross-referenced.
Thomas Dehli, Founder & Editor, Sacred Lotus
Sacred Lotus has published Chinese medicine reference material since 2001. Integrative pages are held to the same standard as the herb and formula library: cite the source, grade the claim at its real strength, and say where the research has not looked. This page is educational and it is not medical advice. Last reviewed and updated August 9, 2026.
Evidence strength
How confidently the research supports a claim. Strength describes the evidence, not our endorsement.